Market Tracker

05/27 6:45pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

19.15
Delayed Data
As of May 27
 +0.37 / +1.97%
Today’s Change
9.51
Today|||52-Week Range
23.30
+42.49%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close18.78
Today’s open18.85
Day’s range18.81 - 19.44
Volume472,746
Average volume (3 months)732,668
Market cap$946.4M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+125.51%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)+18.34%
P/E ratio55.8
Price/Sales4.76
Price/Book7.89

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.13-0.42%
SRPTSarepta Therapeutics...-1.01-4.55%
ZIOPZIOPHARM Oncology In...+0.33+4.67%
FWPForward Pharma A/S-0.83-4.10%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts